BioTrends Research Group LLCPosted on:12 Apr 12 - PharmiWeb.com (press release) PDF Print
PharmiWeb.com (press release)
In the US the market for erythropoietic stimulating agents (ESAs) has undergone significant shifting over the past several years as new clinical data, updated product labeling and a new reimbursement system in dialysis have all changed the market

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.